SERUM CHROMOGRANIN A - A MARKER FOR HORMONE-REFRACTORY CARCINOMA OF PROSTATE - AND FOR PROGNOSIS

被引：0
|
作者：
Bhattacharyya, G. S. [1 ]
Singh, J. K. [2 ]
Singh, M. [2 ]
Basu, S. [3 ]
Vaid, A. K. [4 ]
Parikh, P. [5 ]
Malhotra, H. [6 ]
Babu, K. G. [7 ]
Mukherjhee, S. [8 ]
机构：
[1] Adv Medicare Res Inst Hosp, Kolkata, West Bengal, India
[2] Mahavir Canc Sansthan, Oncol, Patna, Bihar, India
[3] Adv Medicare Res Inst, Kolkata, India
[4] Medicity, Hod Oncol, New Delhi, India
[5] Icon Aro, Bombay, Maharashtra, India
[6] SMS Med Coll Hosp, Jaipur, Rajasthan, India
[7] Kidwai Mem Inst Oncol, Bangalore, Karnataka, India
[8] Biospecialities, Pathol & Biochem, Kolkata, India
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：302 / 302
页数：1
相关论文
共 50 条
  • [41] Revolutions in the management of hormone-refractory prostate cancer
    Abrahamsson, PA
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2003, 2 (03) : 1 - 2
  • [42] The androgen receptor in hormone-refractory prostate cancer
    Mao, Hai-Lei
    Zhu, Zhi-Qi
    Chen, Charlie Degui
    [J]. ASIAN JOURNAL OF ANDROLOGY, 2009, 11 (01) : 68 - 73
  • [43] Therapeutic options for hormone-refractory prostate cancer
    Miller, K.
    Boergermann, C.
    Thueroff, J.
    Albers, P.
    Wirth, M.
    [J]. UROLOGE, 2006, 45 (05): : 580 - +
  • [44] Paclitaxel in the treatment of hormone-refractory prostate cancer
    Smith, DC
    Pienta, KJ
    [J]. SEMINARS IN ONCOLOGY, 1999, 26 (01) : 109 - 111
  • [45] Treatment options for hormone-refractory prostate cancer
    Heidenreich, A
    Ohlmann, CH
    [J]. UROLOGE, 2005, 44 (11): : 1303 - +
  • [46] Oral Chemotherapy in Hormone-Refractory Prostate Carcinoma Patients Unwilling to Be Admitted to Hospital
    Serretta, Vincenzo
    Altieri, Vincenzo
    Morgia, Giuseppe
    Siragusa, Alfredo
    De Grande, Gaetano
    Napoli, Matteo
    Falsaperla, Mario
    Melloni, Darvinio
    Allegro, Rosalinda
    [J]. UROLOGIA INTERNATIONALIS, 2009, 83 (04) : 452 - 457
  • [47] DocetaxelIn Hormone-Refractory Metastatic Prostate Cancer
    Kate McKeage
    Susan J. Keam
    [J]. Drugs, 2005, 65 : 2287 - 2294
  • [48] The role of endothelin in hormone-refractory prostate cancer
    Zonnenberg, BA
    Voest, EE
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2003, 2 (03) : 9 - 14
  • [49] The role of bisphosphonates in hormone-refractory prostate cancer
    Fred Saad
    Pierre Karakiewicz
    Paul Perrotte
    [J]. World Journal of Urology, 2005, 23 : 14 - 18
  • [50] Satraplatin in the treatment of hormone-refractory prostate cancer
    Sternberg, CN
    [J]. BJU INTERNATIONAL, 2005, 96 (07) : 990 - 994
12345